Pharmaceutical unit-dose repackaging and supply chain solutions company Safecor Health, a Vesey Street Capital Partners (VSCP) portfolio company, announced on Monday that it has acquired the US unit-dose packaging business of pharmaceutical company Viatris Inc (NASDAQ:VTRS).
The business was previously called Unit Dose Laboratories (UDL). Established in 1980, it provides unit-dose generic medicines to institutional and long-term care facilities.
The acquisition is expected to be finalised in the first half of 2025, with no immediate action required by customers or partners at this time.
Safecor CEO Mark Saxon, said: "Adding the UDL team, the strong brand recognition, and their capabilities to the Safecor family will further our ongoing goal of providing world-class packaging and supply chain solutions to the manufacturers and health systems we serve. With this addition, we'll immediately increase the number of unit-dose commercial products we offer, and we plan to grow the offering with expanded manufacturer, health system, and wholesaler relationships."
Par Health launches generic version of Janumet XR tablets in US
EQL Pharma gains approval to sell Mellozzan in Kazakhstan
Newbury Pharmaceuticals receives Swedish approval for generic tofacitinib
Breckenridge launches Tofacitinib Tablets, generic equivalent to Pfizer's Xeljanz
Hims & Hers expands GLP-1 offering in Canada with generic semaglutide
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
Transpire Bio's generic high-strength Trelegy Ellipta ANDA accepted for filing by US FDA
Kaiser Permanente reports study findings showing significant cost savings
Apotex receives Health Canada approval for a generic Ozempic equivalent
Cipla's AB-rated Ventolin HFA generic receives US FDA approval
Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules